MedPath

Chloroquine Phosphate

Chloroquine Phosphate Tablet, USP

Approved
Approval ID

ee944d28-f596-4163-a502-e779c0d622bc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 8, 2018

Manufacturers
FDA

Rising Pharmaceuticals, Inc.

DUNS: 041241766

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chloroquine Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64980-177
Application NumberANDA091621
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chloroquine Phosphate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 9, 2018
FDA Product Classification

INGREDIENTS (7)

CHLOROQUINE PHOSPHATEActive
Quantity: 250 mg in 1 1
Code: 6E17K3343P
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Chloroquine Phosphate - FDA Drug Approval Details